Azilsartan 147403-03-0
Azilsartan (rINN; codenamed TAK-491) is an angiotensin II receptor antagonist undergoing research for the treatment of hypertension.
| Systematic (IUPAC) name: |
(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl2-ethoxy-1-([2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl)-1H-benzimidazole-7-carboxylate |
| Azilsartan CAS number: |
147403-03-0 |
| ATC code: |
|
| PubChem: |
|
| DrugBank: |
|
| Formula: |
C30H24N4O8 |
| Molecular mass: |
568.5 g/mol |
| Azilsartan Assay/Purity: |
Typically NLT 98% |
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.
